Abstract
With interest we read the article by Singh et al. about the managementof a 36 years old female with sero-negative myasthenia gravis (MG) who experienced exacerbation of MG during an infection with SARS-CoV-2 [1]. It was concluded that treatment of MG in aSARS-CoV-2 infected patients should be tailored to the individual patient with close monitoring of respiratory functions [1]. We have the following comments and concerns
Full text article
Generated from XML file
Authors
MD, PhD, F. J. (2022). SARS-Cov-2 Infection May Mimic Exacerbation of Seronegative Myasthenia. Journal of Medical Case Reports and Reviews, 4(03). Retrieved from http://jmcrr.info/index.php/jmcrr/article/view/122
Copyright and license info is not available